Cancer Screening Recommendations & Guidelines
Screening saves lives by identifying precancerous lesions or early-stage malignancies long before symptoms occur. Explore official evidence-based guidelines for breast, cervical, colorectal, lung, and prostate cancer screening.
Medical Disclaimer & On-Site Consultation Notice:
This information is educational and does not replace a consultation with your doctor. These guidelines apply to average-risk individuals. High-risk patients with family history or genetic factors require personalized screening. All clinical evaluations are conducted on-site in Udaipur only — no teleconsultation is offered.
Breast Cancer Screening
Women and others assigned female at birth, ages 40 to 74 years, at average risk.
- Ages 40 to 74 years at average risk
- Screening continues through age 74; evidence is insufficient for routine screening after age 74
This low-dose X-ray of the breasts helps detect microcalcifications and early tumors before they can be felt by hand, when treatment is simplest and most effective.
Cervical Cancer Screening
Women ages 21 to 65 years with a cervix, at average risk.
- Ages 21 to 65 years with a cervix, at average risk
- No screening for those under age 21 or over 65 with adequate prior normal results and not high risk
- No screening after total hysterectomy (cervix removal) without a history of high-grade precancerous lesions or cervical cancer
High-risk HPV testing identifies human papillomavirus infections that cause cervical changes. Pap cytology examines cervical cells for precancerous dysplasia.
Colorectal Cancer Screening
Adults ages 45 to 75 years at average risk.
- Adults ages 45 to 75 years at average risk
- Selective screening for ages 76 to 85 based on overall health and prior screening history
- Individualize decisions; benefits decrease with advanced age or limited life expectancy
Options include non-invasive stool testing (annual FIT/gFOBT or 1–3 yr stool DNA) or visual exams (Colonoscopy every 10 yrs, CT Colonography every 5 yrs). Any abnormal stool test must be followed by colonoscopy.
Lung Cancer Screening
Adults ages 50 to 80 years with a 20+ pack-year tobacco history.
- Adults ages 50 to 80 years at high risk due to heavy smoking
- Current smokers or former smokers who quit within the past 15 years with a 20 pack-year history (e.g. 1 pack/day for 20 years or 2 packs/day for 10 years)
- Must be able and willing to undergo curative treatment if cancer is diagnosed
A quick, non-contrast low-radiation chest CT scan that identifies tiny pulmonary nodules in heavy smokers long before symptoms like coughing or hemoptysis appear.
Prostate Cancer Screening
Men ages 55 to 69 years (shared decision-making).
- Men ages 55 to 69 years
- Not routinely recommended for men age 70 and older
Prostate-Specific Antigen (PSA) blood test measures a protein produced by prostate tissue. Elevated levels may indicate benign prostatic hyperplasia, infection, or prostate cancer.
General Guidelines for Patients & Families
These rules apply strictly to average-risk individuals without symptoms. High-risk individuals require tailored early protocols.
Screening saves lives by preventing or diagnosing cancer early, but involves potential harms like false-positive test results.
An abnormal screening test is not a diagnosis. It requires prompt diagnostic follow-up (such as biopsy or colonoscopy) with your doctor.
Frequently Asked Questions About Screening
QWhat are USPSTF screening guidelines?
The US Preventive Services Task Force (USPSTF) publishes evidence-based recommendations for cancer screening in average-risk adults to detect precancerous changes or early-stage cancers before symptoms appear.
QAre these screening guidelines suitable for high-risk individuals?
No. Individuals with a strong family history of cancer, genetic mutations (like BRCA), prior radiation, or hereditary syndromes require tailored, early screening protocols under direct oncologist guidance.
QCan I get screening consultations in Udaipur?
Yes. Cancer screening consultations, mammography guidance, Pap testing, PSA evaluation, and stool/colonoscopy coordination are conducted in-person at MB Hospital Campus, RNT Medical College, Udaipur.
QIs teleconsultation or online booking available for screening?
No. All services are strictly in-person/on-site. Appointments must be scheduled by phone call to the secretary (+91 7597207640) between 2:00 PM and 8:00 PM, Monday to Saturday.
On-Site Screening Consultation Locations
Dr. Narendra Rathore provides on-site radiation oncology and clinical screening consultations for patients traveling from across Southern Rajasthan. Select your district for details:
Schedule Your OPD Consultation
All oncology consultations, scan reviews, and treatment planning with Dr. Narendra Rathore are conducted strictly in-person at MB Hospital campus, Udaipur.
- Original Biopsy & Histopathology Reports
- CT / MRI / PET Scan Films & DICOM CDs
- Prior Doctor Prescriptions & Chemotherapy Records
- Patient Photo ID & Scheme Card (RGHS / Chiranjeevi)